# CTS Corp: overview

CTS · NYSE · CIK 26058 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cts.md) · [Financials](/companies/cts/financials.md) · [Filings](/companies/cts/filings.md) · [Insiders](/companies/cts/insiders.md)

Latest reported revenue: [$149.6m](/filings/0001193125-26-433661.md) for Q3 FY2026, three months to 2026-09-30, from the 10-Q filed Oct 27, 2026 (XBRL us-gaap:Revenues, accession 0001193125-26-433661).

## Last eight quarters

| Line item | Unit | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [126 d](/filings/0001193125-26-067039.md) | [126](/filings/0001193125-26-190431.md) | [135](/filings/0001193125-26-320492.md) | [143](/filings/0001193125-26-433661.md) | [137 d](/filings/0001193125-26-067039.md) | [139](/filings/0001193125-26-190431.md) | [145](/filings/0001193125-26-320492.md) | [150](/filings/0001193125-26-433661.md) |
| Gross margin | % | [37.1% d](/filings/0001193125-26-067039.md) | [37.0%](/filings/0001193125-26-190431.md) | [38.7%](/filings/0001193125-26-320492.md) | [38.7%](/filings/0001193125-26-433661.md) | [39.1% d](/filings/0001193125-26-067039.md) | [39.5%](/filings/0001193125-26-190431.md) | [41.5%](/filings/0001193125-26-320492.md) | [42.2%](/filings/0001193125-26-433661.md) |
| Operating margin | % | [14.2% d](/filings/0001193125-26-067039.md) | [12.9%](/filings/0001193125-26-190431.md) | [16.8%](/filings/0001193125-26-320492.md) | [14.6%](/filings/0001193125-26-433661.md) | [16.5% d](/filings/0001193125-26-067039.md) | [15.8%](/filings/0001193125-26-190431.md) | [18.5%](/filings/0001193125-26-320492.md) | [17.1%](/filings/0001193125-26-433661.md) |
| Net margin | % | [9.1% d](/filings/0001193125-26-067039.md) | [10.6%](/filings/0001193125-26-433661.md) | [13.7%](/filings/0001193125-26-433661.md) | [9.6%](/filings/0001193125-26-433661.md) | [14.4% d](/filings/0001193125-26-067039.md) | [12.4%](/filings/0001193125-26-433661.md) | [13.2%](/filings/0001193125-26-433661.md) | [11.9%](/filings/0001193125-26-433661.md) |
| Diluted EPS | $ per share | not reported | [0.44](/filings/0001193125-26-190431.md) | [0.62](/filings/0001193125-26-320492.md) | [0.46](/filings/0001193125-26-433661.md) | not reported | [0.59](/filings/0001193125-26-190431.md) | [0.66](/filings/0001193125-26-320492.md) | [0.61](/filings/0001193125-26-433661.md) |
| Free cash flow | $m | [18.8 d](/filings/0001193125-26-067039.md) | [11.1](/filings/0001193125-26-190431.md) | [25.1 d](/filings/0001193125-26-320492.md) | [24.2 d](/filings/0001193125-26-433661.md) | [26.0 d](/filings/0001193125-26-067039.md) | [12.3](/filings/0001193125-26-190431.md) | [28.9 d](/filings/0001193125-26-320492.md) | [41.1 d](/filings/0001193125-26-433661.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [513](/filings/0000950170-24-019292.md) | [587](/filings/0000950170-25-027956.md) | [550](/filings/0001193125-26-067039.md) | [515](/filings/0001193125-26-067039.md) | [541](/filings/0001193125-26-067039.md) |
| Gross margin | % | [36.0%](/filings/0000950170-24-019292.md) | [35.9%](/filings/0000950170-25-027956.md) | [34.7%](/filings/0001193125-26-067039.md) | [36.4%](/filings/0001193125-26-067039.md) | [38.4%](/filings/0001193125-26-067039.md) |
| Operating margin | % | [14.9%](/filings/0000950170-24-019292.md) | [15.8%](/filings/0000950170-25-027956.md) | [13.6%](/filings/0001193125-26-067039.md) | [13.8%](/filings/0001193125-26-067039.md) | [15.3%](/filings/0001193125-26-067039.md) |
| Net margin | % | [(8.2%)](/filings/0000950170-24-019292.md) | [10.2%](/filings/0000950170-25-027956.md) | [11.0%](/filings/0001193125-26-067039.md) | [10.8%](/filings/0001193125-26-067039.md) | [12.1%](/filings/0001193125-26-067039.md) |
| Diluted EPS | $ per share | [(1.30)](/filings/0000950170-24-019292.md) | [1.85](/filings/0000950170-25-027956.md) | [1.92](/filings/0001193125-26-067039.md) | [1.81](/filings/0001193125-26-067039.md) | [2.19](/filings/0001193125-26-067039.md) |
| Free cash flow | $m | [70.5](/filings/0000950170-24-019292.md) | [107](/filings/0000950170-25-027956.md) | [74.1](/filings/0001193125-26-067039.md) | [79.6](/filings/0001193125-26-067039.md) | [86.4](/filings/0001193125-26-067039.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/cts/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $293.5m | 4,501,796 |  | Added +97,271 |
| [WASATCH ADVISORS LP](/funds/814133.md) | 2026-06-30 | $234.7m | 3,599,707 |  | Added +1,605,778 |
| [EARNEST PARTNERS LLC](/funds/1102578.md) | 2026-06-30 | $107.7m | 1,651,926 |  | Reduced −63,290 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $82.2m | 1,260,973 |  | Added +48,078 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $79.4m | 1,217,355 |  | Reduced −21,839 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $77.8m | 1,193,348 |  | Reduced −36,247 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $76.8m | 1,176,885 |  | Added +25,805 |
| [GAMCO INVESTORS, INC. ET AL](/funds/807249.md) | 2026-06-30 | $76.3m | 1,170,496 |  | Reduced −28,269 |
| [BROWN ADVISORY INC](/funds/1345929.md) | 2026-06-30 | $64.0m | 981,819 |  | Reduced −39,832 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $49.6m | 760,914 |  | Added +20,851 |

## Recent filings

[All 1,073 filings](/companies/cts/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-27 | 13:38 ET | [10-Q](/filings/0001193125-26-433661.md) | Quarterly report, period 2026-09-30 | 0001193125-26-433661 |
| 2026-10-27 | 13:26 ET | [8-K](/filings/0001193125-26-433580.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-433580 |
| 2026-10-27 | 08:00 ET | [8-K](/filings/0001193125-26-432724.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-432724 |
| 2026-08-05 | 16:44 ET | [SCHEDULE 13D/A](/filings/0000807249-26-000060.md) | Ownership report, active investor, amended | 0000807249-26-000060 |
| 2026-07-28 | 14:10 ET | [10-Q](/filings/0001193125-26-320492.md) | Quarterly report, period 2026-06-30 | 0001193125-26-320492 |
| 2026-07-28 | 08:05 ET | [8-K](/filings/0001193125-26-318919.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-318919 |
| 2026-07-28 | 08:00 ET | [8-K](/filings/0001193125-26-318911.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-318911 |
| 2026-06-25 | 16:00 ET | [8-K](/filings/0001193125-26-282712.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-282712 |
| 2026-05-19 | 16:00 ET | [8-K](/filings/0001193125-26-230702.md) | 5.07 Shareholder vote results | 0001193125-26-230702 |
| 2026-04-29 | 12:40 ET | [10-Q](/filings/0001193125-26-190431.md) | Quarterly report, period 2026-03-31 | 0001193125-26-190431 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-067039.md), filed Feb 24, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 26058
- Tickers: CTS
- Exchange: NYSE
- SIC code: 3672 Printed Circuit Boards
- State of incorporation: IN
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 27, 2026, 13:44 ET. No prices; not investment advice.